SPP1 and immunodeficiency disease: In addition, measuring OPN responses has been proposed to be reliable prognostic indicator for improvement of pulmonary tuberculosis during early phase of treatment [35] and useful tool for testing BCG vaccine safety in vitro before its administration in individuals with underlying immunodeficiencies such as with IFN-γ signaling defects [34].